vs
Side-by-side financial comparison of Korro Bio, Inc. (KRRO) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
Korro Bio, Inc. is the larger business by last-quarter revenue ($1.3M vs $919.3K, roughly 1.4× Laser Photonics Corp). On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -43.1%).
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
KRRO vs LASE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $919.3K |
| Net Profit | — | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | — | -350.0% |
| Net Margin | — | -506.4% |
| Revenue YoY | -43.1% | 28.3% |
| Net Profit YoY | -136.1% | -186.5% |
| EPS (diluted) | — | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.1M | $919.3K | ||
| Q2 25 | $1.5M | $2.6M | ||
| Q1 25 | $2.5M | $2.3M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $0 | $716.7K | ||
| Q2 24 | $0 | $623.4K | ||
| Q1 24 | $0 | $743.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-18.1M | $-4.7M | ||
| Q2 25 | $-25.8M | $-1.8M | ||
| Q1 25 | $-23.4M | $-1.7M | ||
| Q4 24 | — | $586.4K | ||
| Q3 24 | $-21.0M | $-1.6M | ||
| Q2 24 | $-21.8M | $-934.3K | ||
| Q1 24 | $-19.6M | $-545.7K |
| Q4 25 | — | — | ||
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% |
| Q4 25 | — | — | ||
| Q3 25 | -1764.9% | -350.0% | ||
| Q2 25 | -1863.2% | -37.0% | ||
| Q1 25 | -981.2% | -68.7% | ||
| Q4 24 | — | -255.1% | ||
| Q3 24 | — | -238.0% | ||
| Q2 24 | — | -149.4% | ||
| Q1 24 | — | -73.8% |
| Q4 25 | — | — | ||
| Q3 25 | -1657.0% | -506.4% | ||
| Q2 25 | -1765.1% | -68.3% | ||
| Q1 25 | -917.1% | -73.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | — | -226.8% | ||
| Q2 24 | — | -149.9% | ||
| Q1 24 | — | -73.4% |
| Q4 25 | — | — | ||
| Q3 25 | $-1.92 | $-0.27 | ||
| Q2 25 | $-2.74 | $-0.12 | ||
| Q1 25 | $-2.49 | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-2.26 | $-0.13 | ||
| Q2 24 | $-2.43 | $-0.09 | ||
| Q1 24 | $-2.44 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.2M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $51.4M | $4.1M |
| Total Assets | $113.5M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | — | ||
| Q3 25 | $92.5M | $3.6M | ||
| Q2 25 | $96.4M | $78.5K | ||
| Q1 25 | $115.0M | $179.1K | ||
| Q4 24 | — | $533.9K | ||
| Q3 24 | $137.0M | $2.1M | ||
| Q2 24 | $157.4M | $2.7M | ||
| Q1 24 | $138.8M | $5.2M |
| Q4 25 | $51.4M | — | ||
| Q3 25 | $99.0M | $4.1M | ||
| Q2 25 | $115.1M | $4.3M | ||
| Q1 25 | $139.0M | $6.8M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $179.6M | $9.7M | ||
| Q2 24 | $198.1M | $10.3M | ||
| Q1 24 | $151.4M | $12.4M |
| Q4 25 | $113.5M | — | ||
| Q3 25 | $161.6M | $17.5M | ||
| Q2 25 | $180.4M | $14.9M | ||
| Q1 25 | $202.2M | $16.0M | ||
| Q4 24 | — | $17.2M | ||
| Q3 24 | $243.5M | $10.6M | ||
| Q2 24 | $249.6M | $11.1M | ||
| Q1 24 | $198.0M | $13.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-78.6M | $763.1K |
| Free Cash FlowOCF − Capex | $-79.1M | — |
| FCF MarginFCF / Revenue | -6120.7% | — |
| Capex IntensityCapex / Revenue | 40.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-140.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-78.6M | — | ||
| Q3 25 | $-17.2M | $763.1K | ||
| Q2 25 | $-19.2M | $-1.0M | ||
| Q1 25 | $-24.5M | $-1.2M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | $-16.1M | $632.7K | ||
| Q2 24 | $-14.6M | $-2.4M | ||
| Q1 24 | $-21.9M | $-866.3K |
| Q4 25 | $-79.1M | — | ||
| Q3 25 | $-17.4M | — | ||
| Q2 25 | $-19.4M | — | ||
| Q1 25 | $-24.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-21.0M | $589.6K | ||
| Q2 24 | $-20.6M | $-2.4M | ||
| Q1 24 | $-27.5M | $-1.0M |
| Q4 25 | -6120.7% | — | ||
| Q3 25 | -1592.1% | — | ||
| Q2 25 | -1326.6% | — | ||
| Q1 25 | -963.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% |
| Q4 25 | 40.1% | — | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 9.6% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
